Next Article in Journal
Cell Autonomous and Non-Autonomous Functions of IKKβ and NF-κB during the Pathogenesis of Gastrointestinal Tumors
Next Article in Special Issue
Therapeutic Response in Patients with Advanced Malignancies Treated with Combined Dendritic Cell–Activated T Cell Based Immunotherapy and Intensity–Modulated Radiotherapy
Previous Article in Journal
Predictive Factors of the Response of Rectal Cancer to Neoadjuvant Radiochemotherapy
Open AccessReview

Harnessing Dendritic Cells for Tumor Antigen Presentation

Department of Tumor Immunology, Nijmegen Centre for Molecular Life Sciences, Radboud University Nijmegen Medical Centre, Geert Grooteplein 28, Nijmegen 6525 GA, The Netherlands
Division of Molecular Immunology, Cincinnati Children’s Hospital Research Foundation, University of Cincinnati College of Medicine, 3333 Burnet Avenue, Cincinnati, OH 45229, USA
Author to whom correspondence should be addressed.
Cancers 2011, 3(2), 2195-2213;
Received: 14 March 2011 / Revised: 14 April 2011 / Accepted: 19 April 2011 / Published: 26 April 2011
(This article belongs to the Special Issue Cancer Vaccines and Immunotherapy)
Dendritic cells (DC) are professional antigen presenting cells that are crucial for the induction of anti-tumor T cell responses. As a consequence, research has focused on the harnessing of DCs for therapeutic interventions. Although current strategies employing ex vivo-generated and tumor-antigen loaded DCs have been proven feasible, there are still many obstacles to overcome in order to improve clinical trial successes and offset the cost and complexity of customized cell therapy. This review focuses on one of these obstacles and a pivotal step for the priming of tumor-specific CD8+ and CD4+ T cells; the in vitro loading of DCs with tumor antigens. View Full-Text
Keywords: dendritic cell; tumor antigen; antigen presentation; antigen processing dendritic cell; tumor antigen; antigen presentation; antigen processing
MDPI and ACS Style

Nierkens, S.; Janssen, E.M. Harnessing Dendritic Cells for Tumor Antigen Presentation. Cancers 2011, 3, 2195-2213.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Search more from Scilit
Back to TopTop